All sponsors

ModernaTX, Inc. $MRNA

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS14
PHASE 3 / 2-32
RECRUITING7
READOUTS ≤12 MONTHS5
READOUT SLIPPED >6 MO60%

Delay Index: of 10 active trials registered more than a year ago, 6 have moved their primary completion (readout) date by more than 6 months since first registration (median +25.1 months). See all sponsors →

Open ModernaTX, Inc. on the live radar map → 📅 $MRNA readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
mRNA-1189
NCT05164094
P1/2Active, not recruitingEpstein-Barr Virus Infection8672026-10-05 (+39 mo)
mRNA-3745
NCT05095727
P1/2Active, not recruitingGlycogen Storage Disease152026-11-30 (+34 mo)
mRNA-1018-H5
NCT07496450
P3Active, not recruitingInfluenza40502027-01-28
Nova 301
NCT06592794
P3Active, not recruitingAcute Gastroenteritis; Norovirus Acute Gastroenteritis378642027-02-15 (-3 mo)
mRNA-1647
NCT05683457
P2Active, not recruitingCytomegalovirus Infection842027-03-06 (+25 mo)
mRNA-3927
NCT04159103
P1/2RecruitingPropionic Acidemia772027-08-31 (+51 mo)
mRNA-1982
NCT07561294
P2Active, not recruitingLyme Disease3662028-11-09
mRNA-1195
NCT06735248
P2RecruitingMultiple Sclerosis1802029-01-08
mRNA-1283
NCT07808697
P2RecruitingSARS-CoV-23002029-08-30
mRNA-3927
NCT05130437
P1/2RecruitingPropionic Acidemia502029-12-04
mRNA-2808
NCT07116616
P1/2RecruitingRelapsed or Refractory Multiple Myeloma1902030-06-17
mRNA-4359
NCT05533697
P1/2RecruitingAdvanced Solid Tumors3612032-02-18 (+50 mo)
mRNA-4157
NCT03897881
P2Active, not recruitingMelanoma2672032-11-21
mRNA-3705
NCT05295433
P1/2RecruitingMethylmalonic Acidemia562034-04-02 (+24 mo)